Large-scale testing (Phase 3)Study completedNCT04082364
What this trial is testing
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer
Who this might be right for
Gastric CancerGastroesophageal Junction CancerHER2-positive Gastric Cancer
MacroGenics 82